Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Deodhar

Showing results (81-90 of 272) with videos related to

Pageof 28
Sort By:
Arthritis Care & Research|December 8, 2010
Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature reviewStanley B Cohen, Hollis Potter, Atul Deodhar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2019
Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?Daniel M Hartung, Kirbee Johnston, Atul Deodhar, et al.
International Journal of Rheumatology|January 22, 2016
Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational InvestigationMohammed Hammoudeh, Hanan Al Rayes, Adel Alawadhi, et al.
Clinical Rheumatology|November 26, 2014
Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritisAbhijeet Danve, Anusha Reddy, Kiana Vakil-Gilani, et al.
Current Rheumatology Reports|January 12, 2024
Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)Joerg Ermann, Atul Deodhar, Muhammad Asim Khan, et al.
Clinical Rheumatology|November 24, 2020
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literatureFrancisco Airton Castro Rocha, Ana Carolina Matias Dinelly Pinto, Jailson Rodrigues Lopes, et al.
The Journal of Rheumatology|August 2, 2008
Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositisJoseph R Lutt, Mary L Pisculli, Michael E Weinblatt, et al.
Clinical Rheumatology|March 19, 2016
Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delayAtul Deodhar, Manish Mittal, Patrick Reilly, et al.
Clinical Rheumatology|May 3, 2019
Use of machine learning techniques in the development and refinement of a predictive model for early diagnosis of ankylosing spondylitisAtul Deodhar, Martin Rozycki, Cody Garges, et al.
Rheumatology and Therapy|July 5, 2025
Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc AnalysisAtul Deodhar, Miroslawa Nowak, June Y Ye, et al.
Pageof 28

Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Arthritis Care & Research|December 8, 2010
Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature reviewStanley B Cohen, Hollis Potter, Atul Deodhar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2019
Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?Daniel M Hartung, Kirbee Johnston, Atul Deodhar, et al.
International Journal of Rheumatology|January 22, 2016
Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational InvestigationMohammed Hammoudeh, Hanan Al Rayes, Adel Alawadhi, et al.
Clinical Rheumatology|November 26, 2014
Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritisAbhijeet Danve, Anusha Reddy, Kiana Vakil-Gilani, et al.
Current Rheumatology Reports|January 12, 2024
Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)Joerg Ermann, Atul Deodhar, Muhammad Asim Khan, et al.
Clinical Rheumatology|November 24, 2020
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literatureFrancisco Airton Castro Rocha, Ana Carolina Matias Dinelly Pinto, Jailson Rodrigues Lopes, et al.
The Journal of Rheumatology|August 2, 2008
Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositisJoseph R Lutt, Mary L Pisculli, Michael E Weinblatt, et al.
Clinical Rheumatology|March 19, 2016
Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delayAtul Deodhar, Manish Mittal, Patrick Reilly, et al.
Clinical Rheumatology|May 3, 2019
Use of machine learning techniques in the development and refinement of a predictive model for early diagnosis of ankylosing spondylitisAtul Deodhar, Martin Rozycki, Cody Garges, et al.
Rheumatology and Therapy|July 5, 2025
Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc AnalysisAtul Deodhar, Miroslawa Nowak, June Y Ye, et al.
Pageof 28